Key drivers behind GLP-1 and addiction research include: Rapid expansion in the use of GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Maunjaro and Zepbound) Reports of changes in cravings, alcohol use, or reward-seeking behaviors beyond weight loss Increased public conversation and clinical curiosity about psychological and behavioral effects Scientific interest in GLP-1 activity within reward pathways and dopamine signaling Recognition that appetite regulation and addiction involve shared neural mechanisms This research is still emerging, and findings should be interpreted with caution
Lee, Karen (2021) Coupons and Canned Corn: What a WWII Shopping List Reveals about Rationing. Fishwrap: Official Blog of Newspapers.com, August 21, 2021
If you have diabetic complications or wound healing concerns, Remy laser therapy can be added alongside the regenerative protocol to support cellular repair at a deeper level
[51,53,54,55,56,57,58,59,60]), but a priori , there is no way of knowing whether any of the above conditions are truly on a causal pathway or simply covariates (and caused by other factors such as those labelled X and Y in Figure 2)
It is listed as a research-only compound for analytical and experimental workflows
The consistency of these improvements across study visits suggested sustained metabolic benefit rather than temporary fluctuations